Telomerase inhibitors as novel antitumor drugs

被引：0
|
作者：
A. I. Glukhov
L. V. Svinareva
S. E. Severin
V. I. Shvets
机构：
[1] Sechenov Medical Academy,
[2] Moscow Research Institute of Medical Ecology,undefined
[3] Lomonosov Moscow State Academy of Fine Chemical Technology,undefined
来源：
Applied Biochemistry and Microbiology | 2011年 / 47卷
关键词：
antisense therapy; immortalization; G-quadruplex; ribozyme; RNA interference; telomerase activity;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
Telomerase activity is detected in most types of human tumors, but it is almost undetectable in normal somatic cells; therefore, telomerase is a promising therapeutic target. The present review describes various approaches to telomerase inhibition, namely, antisense therapy, RNA interference, and the use of ribozymes and agents interacting with the telomeric G-quadruplex. The use of these compounds in clinical research is analyzed in the review.
引用
收藏
页码：655 / 660
页数：5
相关论文
共 50 条
  • [1] Telomerase Inhibitors as Novel Antitumor Drugs
    Glukhov, A. I.
    Svinareva, L. V.
    Severin, S. E.
    Shvets, V. I.
    APPLIED BIOCHEMISTRY AND MICROBIOLOGY, 2011, 47 (07) : 655 - 660
  • [2] Novel telomerase inhibitors
    不详
    DRUG DISCOVERY TODAY, 2001, 6 (13) : 700 - 701
  • [3] TELOMERASE: A NOVEL TARGET OF ANTITUMOR AGENTS
    张如刚
    袁金辉
    王兴旺
    胥彬
    谢弘
    Chinese Journal of Cancer Research, 2000, (01) : 39 - 45
  • [4] Mechanisms of the Antiproliferative and Antitumor Activity of Novel Telomerase-Carbonic Anhydrase Dual-Hybrid Inhibitors
    Plyasova, Anna A.
    Berrino, Emanuela
    Khan, Irina I.
    Veselovsky, Alexander V.
    Pokrovsky, Vadim S.
    Angeli, Andrea
    Ferraroni, Marta
    Supuran, Claudiu T.
    Pokrovskaya, Marina, V
    Alexandrova, Svetlana S.
    Gladilina, Yulia A.
    Sokolov, Nikolay N.
    Hilal, Abdullah
    Carta, Fabrizio
    Zhdanov, Dmitry D.
    JOURNAL OF MEDICINAL CHEMISTRY, 2021, 64 (15) : 11432 - 11444
  • [5] Novel small molecule inhibitors of telomerase
    Adekunle, A.
    Evans, H. R.
    Phillips, V. A.
    Pletsas, D.
    Wheelhouse, R. T.
    Parkin, S. M.
    Watt, D. A. L.
    Sharpe, D. T. S.
    Phillips, R. M.
    EJC SUPPLEMENTS, 2008, 6 (12): : 139 - 139
  • [6] Synthetic urokinase inhibitors as potential antitumor drugs
    Steinmetzer, T
    IDRUGS, 2003, 6 (02) : 138 - 146
  • [7] Is there a role for glyoxalase I inhibitors as antitumor drugs?
    Tew, KD
    DRUG RESISTANCE UPDATES, 2000, 3 (05) : 263 - 264
  • [8] Biological Testing of Novel Telomerase Inhibitors.
    Uhl, K. L.
    Sridhar, S.
    Smart, R.
    Schroeder, W.
    MOLECULAR BIOLOGY OF THE CELL, 2014, 25
  • [9] STUDY SUGGESTS TELOMERASE INHIBITORS COULD BE EFFECTIVE ANTICANCER DRUGS
    BORMAN, S
    CHEMICAL & ENGINEERING NEWS, 1994, 72 (17) : 42 - 44
  • [10] Characterization and antitumor activity of triethylene tetramine, a novel telomerase inhibitor
    Liu, Jianhui
    Guo, Lixia
    Yin, Fei
    Zheng, Xuxu
    Chen, Gang
    Wang, Yun
    BIOMEDICINE & PHARMACOTHERAPY, 2008, 62 (07) : 480 - 485
12345